Jen-Shi Chen Selected Research

Analgesics (Analgesic Drugs)

4/2020	Satisfaction with pain management and impact of pain on quality of life in cancer patients.
8/2019	A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life.
5/2019	Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study.
11/2017	Cancer-related pain: a nationwide survey of patients' treatment modification and satisfaction in Taiwan.
1/2017	Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan.
11/2015	The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in Taiwan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jen-Shi Chen Research Topics

Disease

92	Neoplasms (Cancer) 04/2024 - 06/2003
22	Adenocarcinoma 03/2024 - 11/2011
21	Stomach Neoplasms (Stomach Cancer) 03/2023 - 06/2003
14	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 11/2009
14	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 12/2011
12	Pain (Aches) 04/2023 - 06/2004
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
10	Disease Progression 01/2022 - 01/2007
8	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 07/2015
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2002
8	Breast Neoplasms (Breast Cancer) 12/2019 - 01/2007
6	Cancer Pain 04/2023 - 01/2010
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2019 - 02/2011
5	Death (Near-Death Experience) 01/2022 - 12/2009
5	Hematologic Neoplasms (Hematological Malignancy) 08/2019 - 12/2009
5	Carcinoma (Carcinomatosis) 09/2012 - 06/2003
5	Nausea 02/2011 - 02/2003
5	Vomiting 02/2011 - 02/2003
4	Neutropenia 10/2021 - 01/2007
4	Fatigue 01/2019 - 01/2007
4	Diarrhea 11/2013 - 07/2003
3	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 01/2004
3	Venous Thromboembolism 06/2022 - 12/2018
3	Thrombocytopenia (Thrombopenia) 11/2021 - 07/2003
3	Squamous Cell Carcinoma of Head and Neck 04/2019 - 06/2002
3	Hypertension (High Blood Pressure) 11/2018 - 07/2013
3	Margins of Excision 01/2018 - 01/2014
2	Hypersensitivity (Allergy) 04/2024 - 10/2009
2	Drug-Related Side Effects and Adverse Reactions 04/2024 - 08/2010
2	Frailty 01/2023 - 11/2021
2	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2016
2	Circulating Neoplastic Cells 09/2022 - 04/2019
2	Heart Failure 06/2022 - 01/2022
2	Ischemic Stroke 06/2022 - 01/2022
2	Atrial Fibrillation 06/2022 - 11/2018
2	Sepsis (Septicemia) 01/2022 - 10/2021
2	Hyponatremia 11/2021 - 01/2011
2	Heart Arrest (Cardiac Arrest) 10/2021 - 12/2009
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 07/2014
2	Cardiotoxicity 10/2020 - 05/2015
2	Cholangiocarcinoma 01/2020 - 01/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 05/2019 - 04/2019
2	Thromboembolism 11/2018 - 07/2013
2	Mucositis 10/2014 - 01/2007

Drug/Important Bio-Agent (IBA)

25	Gemcitabine FDA Link 03/2024 - 06/2003
22	Leucovorin (Folinic Acid)FDA Link 03/2024 - 06/2002
21	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 09/2002
19	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 06/2002
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 01/2005
11	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 11/2011
11	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 12/2011
10	Sunitinib (Sutent)FDA Link 01/2022 - 02/2011
8	TegafurIBA 09/2013 - 06/2002
6	NivolumabIBA 01/2022 - 12/2017
6	Analgesics (Analgesic Drugs)IBA 04/2020 - 11/2015
5	regorafenibIBA 01/2022 - 07/2017
5	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2009
5	UracilIBA 09/2013 - 09/2002
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 02/2011
4	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2014
4	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2020
4	AnthracyclinesIBA 05/2015 - 01/2007
4	Docetaxel (Taxotere)FDA Link 01/2012 - 01/2007
3	AntigensIBA 01/2023 - 06/2004
3	ErbB Receptors (EGF Receptor)IBA 09/2022 - 05/2015
3	AlbuminsIBA 01/2022 - 01/2019
3	taxaneIBA 05/2015 - 01/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2008 - 10/2004
2	durvalumabIBA 11/2023 - 08/2022
2	Opioid Analgesics (Opioids)IBA 04/2023 - 02/2023
2	Buprenorphine (Subutex)FDA LinkGeneric 04/2023 - 02/2023
2	B7-H1 AntigenIBA 03/2023 - 01/2021
2	pembrolizumabIBA 03/2023 - 01/2021
2	CarbohydratesIBA 01/2023 - 01/2015
2	GSK2830371IBA 01/2022 - 07/2021
2	ripretinibIBA 01/2022 - 01/2022
2	SodiumIBA 01/2022 - 01/2011
2	Alkaline PhosphataseIBA 06/2021 - 05/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018 - 01/2012
2	Aurora Kinase AIBA 09/2018 - 06/2014
2	Chromogranin AIBA 10/2014 - 01/2012

Therapy/Procedure

56	Drug Therapy (Chemotherapy) 11/2023 - 09/2002
30	Therapeutics 01/2023 - 01/2004
18	Terminal Care (Care, Terminal) 07/2022 - 09/2009
11	Adjuvant Chemotherapy 01/2023 - 01/2011
10	Cardiopulmonary Resuscitation (CPR) 07/2022 - 12/2009
9	Artificial Respiration (Mechanical Ventilation) 07/2022 - 12/2009
8	Gastrectomy 01/2023 - 11/2013
8	Palliative Care (Palliative Therapy) 01/2019 - 09/2011
6	Hospice Care (Care, Bereavement) 07/2022 - 11/2010
6	Pain Management 04/2020 - 01/2010
5	Enteral Nutrition (Feeding, Tube) 01/2022 - 11/2017
4	Immunotherapy 11/2023 - 10/2009
3	Radiotherapy 01/2023 - 10/2007
3	Salvage Therapy 01/2022 - 09/2002
2	Aftercare (After-Treatment) 11/2021 - 05/2015
2	Heart Massage 01/2019 - 11/2017
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 11/2013
2	Chemoradiotherapy 11/2014 - 12/2011
2	Induction Chemotherapy 11/2014 - 12/2011